Home � Products & Services � Benchmarking Reports � Medical Affairs � Medical Education

Building a Foundational Global Function for Reviewing IME Grants

Download FREE Excerpt

ID: POP-382

Features:

8 Info Graphics

19 Data Graphics

250+ Metrics

52 Narratives

Pages: 36

Published: 2024

Delivery Format: Shipped

License Options:
$4000 - 1 user
$12000 - Up to 5 users
$20000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

Independent medical education (IME) grants programs serve as a unique platform for biopharma organizations to support high-quality, evidence-based educational initiatives for healthcare professionals, patients, payers, and systems worldwide. To fulfill this important mission for the organization, a structured and efficient management approach toward IME grants is crucial to ensure optimal resource utilization and impactful educational outcomes.

Best Practices, LLC conducted this benchmarking study to explore how biopharma organizations can optimize their grants review process to identify and address critical educational gaps proactively. The report examines the key roles and activities of global IME groups, focusing on structuring grant review processes to maximize IME budgets and ensure the highest possible impact.

Video Brief:

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Alkermes; Astellas; Baxter International; Dermavant Sciences; GRAIL; Grifols; Merck; OTSUKA; Sage Therapeutics; Sanofi; Vertex Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 13 Medical leaders from 13 companies spanning 22 therapeutic areas through a comprehensive benchmarking survey. Follow-up interviews were conducted to gain deeper insights into the data and approaches described. Most participants represented mid-cap biopharma organizations.

Key topics covered in this report include:

IME Grants Review Process and Systems
Staffing Levels and Alignment for Grant Management
Grants Program Measurement and Performance
Field Medical Support for IME
IME Grants Budget Allocation
Future Trends and Lessons Learned

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

IME Grants Process Milestones: Submission, Review and Decision phases are used by all organizations to track the IME Grants process, and 73% also track the Discussion phase.

IME Grants Budget Allocation: The North American market receives 81% of IME Grants’ overall organizational funding. Most of the remaining funds are allocated to the European (9%) and APAC (4%) markets.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Study Background and Benchmark Class	Pg. 3-5
II.	Executive Summary	Pg. 6-10
III.	IME Grant Review Phases and Milestones	Pg. 11-19
IV.	Technology and Innovation in IME Grant Review	Pg. 20-24
V.	Global IME Structure & Grants Management	Pg. 25-33
VI.	Participant Demographics	Pg. 34-35
VII.	About Best Practices, LLC	Pg. 36

List of Charts & Exhibits

I. Study Background and Benchmark Class

Study background
Benchmark study partners

II. Executive Summary

One-page study summary
Key study insights for Medical leadership

III. IME Grant Review Phases and Milestones

Milestones and timelines employed by benchmark organizations to manage the IME grants process
Average duration for each IME grant review phase
Key elements to include on grant evaluation checklists
Criteria for choosing offline reviews versus live meetings
Information provided by IME operations teams to committees as a pre-read and during meetings
Grant review approaches
Number of global IME staff members dedicated to grant management and total grants processed by these FTEs
Key performance indicators for evaluating overall grants management effectiveness

IV. Technology and Innovation in IME Grant Review

Software used by Medical Education groups to evaluate and manage the grants review process and the tenure of use
Functions or work streams with shared access to the system
Utilization of field medical staff to supplement the distribution of invitations for company-supported IME programs
Key strengths and major areas for improvement in current IME performance

V. Global IME Structure and Grants Management

Allocation of the total organizational budget for IME grants across key markets
Teams responsible for key activities in the grants review process
Alignment of global IME staff members within the organization
Total number of FTEs employed in the global IME group
Percentage of time spent on IME activities
Most important trends in global governance for IME leaders to monitor over the next 2-3 years
Top lessons for running an efficient and impactful grants program

VI. Participant Demographics

Therapeutic areas represented by benchmark partners

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
651C496ADDFB7F03A00258B2D0035E107
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-foundational-global-function-for-reviewing-ime-grants
18
19
20108.162.216.207
21
22
23527255.sherryhk.tech
24/bestp/domrep.nsf
25BMR